Prolacta Bioscience donates to Susan G. Komen for the Cure
Jan 26, 2011
Prolacta Bioscience, a leading provider of human milk fortifier for premature and critically ill infants, will donate $15,000 to the breast cancer organization Susan G. Komen for the Cure.
Prolacta agreed to donate one dollar to Komen for every ounce of qualified breast milk procured through the organization, Helping Hands Milk Bank. Prolacta Bioscience is one of the only companies in the world to offer fortifier made from 100% human breast milk, specially designed for infants born weighing less than 1250 grams.
"With every ounce donated, and every dollar we donate to Komen, we are supporting the ongoing yet promising fight against breast cancer. We hope that this partnership also highlights the link between breastfeeding and a reduced risk of breast cancer in women," said Scott Elseter, CEO of Prolacta Bioscience.
Prolacta has agreed to an annual commitment of $25,000, and this initial donation is just the first step for 2011. Komen and Prolacta hope to continue their partnership and educate women about the relationship between breastfeeding and a reduced risk of breast cancer.
Susan G. Komen for the Cure is the largest breast cancer organization in the world, investing more than $1.5 billion since 1982.